New York State Common Retirement Fund’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $575K | Hold |
|
|||||
|
2025
Q2 | $453K | Hold |
|
|||||
|
2025
Q1 | $404K | Hold |
|
|||||
|
2024
Q4 | $562K | Hold |
|
|||||
|
2024
Q3 | $756K | Sell |
|
|||||
|
2024
Q2 | $1.1M | Buy |
|
|||||
|
2024
Q1 | $1.12M | Buy |
|
|||||
|
2023
Q4 | $877K | Sell |
|
|||||
|
2023
Q3 | $654K | Buy |
|
|||||
|
2023
Q2 | $779K | Sell |
|
|||||
|
2023
Q1 | $991K | Sell |
|
|||||
|
2022
Q4 | $1.46M | Sell |
|
|||||
|
2022
Q3 | $920K | Buy |
|
|||||
|
2022
Q2 | $879K | Sell |
|
|||||
|
2022
Q1 | $1.11M | Buy |
|
|||||
|
2021
Q4 | $1.26M | Buy |
|
|||||
|
2021
Q3 | $1.65M | Sell |
|
|||||
|
2021
Q2 | $1.12M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $264K | Hold |
|
|||||
|
2017
Q4 | $322K | Buy |
|
|||||
|
2017
Q3 | $273K | Hold |
|
|||||
|
2017
Q2 | $236K | Sell |
|
|||||
|
2017
Q1 | $422K | Hold |
|
|||||
|
2016
Q4 | $414K | Hold |
|
|||||
|
2016
Q3 | $473K | Hold |
|
|||||
|
2016
Q2 | $514K | Sell |
|
|||||
|
2016
Q1 | $729K | Hold |
|
|||||
|
2015
Q4 | $3.02M | Sell |
|
|||||
|
2015
Q3 | $2.27M | Buy |
|
|||||
|
2015
Q2 | $5.15M | Buy |
|
|||||
|
2015
Q1 | $4.94M | Buy |
|
|||||
|
2014
Q4 | $2.79M | Buy |
|
|||||
|
2014
Q3 | $1.67M | Hold |
|
|||||
|
2014
Q2 | $2.1M | Sell |
|
|||||
|
2014
Q1 | $8.37M | Buy |
|
|||||
|
2013
Q4 | $10.3M | Buy |
|